Cover Image
市場調查報告書

自體免疫疾病診斷的全球市場 (∼2022年):消耗品、化驗套件、設備、服務

Autoimmune Disease Diagnosis Market by Products (Consumables, Assay Kits, Instruments, Services), Test Type (Inflammatory Markers, Autoantibodies), Disease (RA, SLE, Thyroiditis, Scleroderma), End Users - Global Forecast to 2022

出版商 MarketsandMarkets 商品編碼 602270
出版日期 內容資訊 英文 123 Pages
訂單完成後即時交付
價格
Back to Top
自體免疫疾病診斷的全球市場 (∼2022年):消耗品、化驗套件、設備、服務 Autoimmune Disease Diagnosis Market by Products (Consumables, Assay Kits, Instruments, Services), Test Type (Inflammatory Markers, Autoantibodies), Disease (RA, SLE, Thyroiditis, Scleroderma), End Users - Global Forecast to 2022
出版日期: 2018年01月29日 內容資訊: 英文 123 Pages
簡介

自體免疫疾病診斷的市場在預測期間內預計以8.9%的年複合成長率發展,從2017年的30億9000萬美元,成長到2022年的47億3000萬美元的規模。自體免疫疾病的罹患率的上升,醫療費的擴大,美國獲得醫療保險的擴大,診斷設備的技術進步等要素促進該市場的成長。

本報告提供全球自體免疫疾病診斷的市場調查,市場定義和概要,市場成長的各種影響因素及市場機會分析,各產品&服務區分、試驗類型、疾病、終端用戶、地區/主要國家趨勢與市場規模的變化與預測,競爭環境,主要企業簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 富有魅力的市場機會
  • 亞洲市場:試驗類型
  • 地區概要
  • 各終端用戶市場

第5章 市場概要

  • 簡介
  • 市場動態
    • 成長推動因素
    • 阻礙成長要素
    • 市場機會
    • 趨勢

第6章 市場分析、預測:各產品與服務

  • 簡介
  • 消耗品、化驗套件
  • 設備
  • 服務

第7章 市場分析、預測:各試驗類型

  • 簡介
  • 日常檢驗
  • 發炎標記
  • 自我抗體檢驗、免疫檢驗
  • 其他

第8章 市場分析、預測:各疾病

  • 簡介
  • 類風濕性關節炎
  • 全身性紅斑性狼瘡
  • 乾燥症(修格蘭氏症候群)
  • 甲狀腺炎
  • 硬皮症
  • 其他

第9章 市場分析、預測:各終端用戶

  • 簡介
  • 臨床實驗室
  • 醫院
  • 其他

第10章 市場分析、預測:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
  • 亞洲
    • 中國
    • 日本
    • 印度
    • 其他
  • 其他地區

第11章 競爭環境

  • 概要
  • 市場佔有率分析
  • 競爭模式
    • 產品的投入
    • 聯盟
    • 收購
    • 聯盟

第12章 企業簡介

  • SIEMENS
  • ABBOTT
  • THERMO FISHER SCIENTIFIC
  • DANAHER
  • BIO-RAD LABORATORIES
  • GRIFOLS
  • TRINITY BIOTECH
  • INOVA DIAGNOSTICS
  • HYCOR BIOMEDICAL
  • EUROIMMUN
  • PROTAGEN

第13章 附錄

目錄
Product Code: MD 5936

"The autoimmune disease diagnosis market projected to grow at a CAGR of 8.9% during the forecast period."

The global autoimmune disease diagnosis market is expected to reach USD 4.73 billion by 2022 from USD 3.09 billion in 2017, at a CAGR of 8.9%. Factors driving the growth of this market include the rising incidence of autoimmune diseases, growing healthcare expenditure, increasing access to medical insurance in the US, and technological advancements in diagnosis devices. On the other hand, the high cost of analyzers and other instruments is expected to challenge market growth to a certain extent.

"The consumables and assay kits segment is anticipated to grow at the fastest growth rate during the forecast period."

The autoimmune disease diagnosis market by product and service is categorized into consumables & assay kits, instruments, and services. The consumables and assay kits segment is expected to register the highest CAGR during the forecast period. The growing adoption of consumables and assay kits for the diagnosis of autoimmune diseases is the key factors driving the growth of this market.

"The routine laboratory tests segment is anticipated to grow at the fastest growth rate during the forecast period."

The autoimmune disease diagnosis market by test type is categorized into routine laboratory tests, inflammatory markers, autoantibodies and immunologic tests, and other tests. The routine laboratory test segment is expected to register the highest CAGR during the forecast period. The growth of this segment is mainly driven by the increasing adoption of routine laboratory tests for a variety of diseases.

"The rheumatoid arthritis segment is anticipated to grow at the fastest growth rate during the forecast period."

The autoimmune disease diagnosis market by disease is categorized into systemic lupus erythematosus, rheumatoid arthritis, Sjogren's syndrome, thyroiditis, scleroderma, and other diseases. The rheumatoid arthritis segment is expected to register the highest CAGR during the forecast period. The growing use of instruments and consumables for the diagnosis and treatment of rheumatoid arthritis, increasing awareness regarding autoimmune diseases, and the development of novel products are the key factors driving the growth of this market.

"The clinical laboratories segment is estimated to grow at a rapid rate during the forecast period"

By end user, the autoimmune disease diagnosis market is segmented into clinical laboratories, hospitals, and other end users. The clinical laboratories segment is expected to grow at highest CAGR during the forecast period. Factors such as the rising number of patients suffering from autoimmune diseases and improving healthcare infrastructure are driving the growth of this segment.

"Asia is estimated to grow at the highest CAGR during the forecast period"

Geographically, the autoimmune disease diagnosis market is dominated by North America, followed by Europe in 2017, however, Asia is estimated to grow at the fastest rate during the forecast period. Growth in this region can be attributed to developing healthcare infrastructure, rising burden of autoimmune diseases, and increasing initiatives to promote the use of novel technologies for autoimmune disease diagnosis in Asian countries.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1 - 70% and Tier 2 - 30%
  • By Designation - C level - 62%, Director level - 21%, Others - 17%
  • By Region - North America - 50%, Asia- 30%, Europe - 20%

The key players in the autoimmune disease diagnosis market include Thermo Fisher Scientific. (US), Danaher (US), HYCOR Biomedical (US), Siemens (Germany), Bio-Rad (US), Inova Diagnostics (US), Trinity Biotech (Ireland), GRIFOLS. (Spain), and Abbott (US).

Research Coverage:

The report analyses the autoimmune disease diagnosis market by product, test type, disease, end user, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.

Key Benefits of Buying the Report:

This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the autoimmune disease diagnosis market
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the autoimmune disease diagnosis market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the autoimmune disease diagnosis market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various autoimmune disease diagnosis and services across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the autoimmune disease diagnosis market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. DEFINITION
  • 1.3. STUDY SCOPE
  • 1.4. YEARS CONSIDERED FOR THE STUDY
  • 1.5. CURRENCY
  • 1.6. LIMITATIONS
  • 1.7. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY type, DESIGNATION, and region
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. BOTTOM-UP APPROACH
    • 2.2.2. TOP-DOWN APPROACH
  • 2.3. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. ATTRACTIVE MARKET OPPORTUNITIES IN AUTOIMMUNE DISEASE DIAGNOSIS MARKET
  • 4.2. ASIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE
  • 4.3. GEOGRAPHICAL SNAPSHOT OF THE GLOBAL AUTOIMMUNE DISEASE DIAGNOSIS MARKET
  • 4.4. AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. High incidence and large economic burden of autoimmune diseases
      • 5.2.1.2. Increasing access to medical insurance in the US
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High capital requirements
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Growth opportunities in emerging countries
      • 5.2.3.2. Increasing number of awareness programs for autoimmune diseases
    • 5.2.4. TRENDS
      • 5.2.4.1. Growth in the number of reagent rental agreements

6. AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT & SERVICE

  • 6.1. INTRODUCTION
  • 6.2. CONSUMABLES AND ASSAY KITS
  • 6.3. INSTRUMENTS
  • 6.4. SERVICES

7. AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE

  • 7.1. INTRODUCTION
  • 7.2. ROUTINE LABORATORY TESTS
  • 7.3. INFLAMMATORY MARKERS
  • 7.4. AUTOANTIBODIES AND IMMUNOLOGIC TESTS
  • 7.5. OTHER TESTS

8. AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE

  • 8.1. INTRODUCTION
  • 8.2. RHEUMATOID ARTHRITIS
  • 8.3. SYSTEMIC LUPUS ERYTHEMATOSUS
  • 8.4. SJOGREN'S SYNDROME
  • 8.5. THYROIDITIS
  • 8.6. SCLERODERMA
  • 8.7. OTHER DISEASES

9. AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. CLINICAL LABORATORIES
  • 9.3. HOSPITALS
  • 9.4. OTHER END USERS

10. AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. US
    • 10.2.2. CANADA
  • 10.3. EUROPE
  • 10.4. ASIA
    • 10.4.1. CHINA
    • 10.4.2. JAPAN
    • 10.4.3. INDIA
    • 10.4.4. REST OF ASIA (ROA)
  • 10.5. REST OF THE WORLD

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. MARKET SHARE ANALYSIS, 2016
  • 11.3. COMPETITIVE SCENARIO
    • 11.3.1. PRODUCT LAUNCHES
    • 11.3.2. PARTNERSHIPS
    • 11.3.3. ACQUISITIONS
    • 11.3.4. COLLABORATIONS

12. COMPANY PROFILES (Business Overview, Products Offered, MnM View.)*

  • 12.1. SIEMENS
  • 12.2. ABBOTT
  • 12.3. THERMO FISHER SCIENTIFIC
  • 12.4. DANAHER
  • 12.5. BIO-RAD LABORATORIES
  • 12.6. GRIFOLS
  • 12.7. TRINITY BIOTECH
  • 12.8. INOVA DIAGNOSTICS
  • 12.9. HYCOR BIOMEDICAL
  • 12.10. EUROIMMUN
  • 12.11. PROTAGEN

*Business Overview, Products Offered, MnM View might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INSIGHTS FROM INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS
  • 13.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCTS & SERVICES, 2015-2022 (USD MILLION)
  • TABLE 2: AUTOIMMUNE DISEASE DIAGNOSIS CONSUMABLES AND ASSAY KITS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 3: AUTOIMMUNE DISEASE DIAGNOSIS INSTRUMENTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 4: AUTOIMMUNE DISEASE DIAGNOSIS SERVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 5: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2015-2022 (USD MILLION)
  • TABLE 6: AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR ROUTINE LABORATORY TESTS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR INFLAMMATORY MARKERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR AUTOANTIBODIES AND IMMUNOLOGIC TESTS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 9: AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR OTHER TESTS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 11: AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR RHEUMATOID ARTHRITIS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR SLE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR SJOGREN'S SYNDROME, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 14: AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR THYROIDITIS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR SCLERODERMA, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 16: AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR OTHER DISEASES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 18: AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR HOSPITALS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR OTHER END USERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 21: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 22: NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 23: NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 24: NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2015-2022 (USD MILLION)
  • TABLE 25: NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 26: NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 27: US: AUTOIMMUNE DISEASE PREVALENCE, 2016
  • TABLE 28: US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 29: US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2015-2022 (USD MILLION)
  • TABLE 30: US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 31: US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 32: CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 33: CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2015-2022 (USD MILLION)
  • TABLE 34: CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 35: CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 36: EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 37: EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2015-2022 (USD MILLION)
  • TABLE 38: EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 39: EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 40: ASIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY COUNTRY, 015-2022 (USD MILLION)
  • TABLE 41: ASIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 42: ASIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2015-2022 (USD MILLION)
  • TABLE 43: ASIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 44: ASIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 45: CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 46: CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2015-2022 (USD MILLION)
  • TABLE 47: CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 48: CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 49: JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 50: JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2015-2022 (USD MILLION)
  • TABLE 51: JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 52: JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 53: INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 54: INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2015-2022 (USD MILLION)
  • TABLE 55: INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 56: INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 57: ROA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 58: ROA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2015-2022 (USD MILLION)
  • TABLE 59: ROA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 60: ROA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 61: ROW: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
  • TABLE 62: ROW: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2015-2022 (USD MILLION)
  • TABLE 63: ROW: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2015-2022 (USD MILLION)
  • TABLE 64: ROW: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2015-2022 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: MARKET SEGMENTATION
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: AUTOIMMUNE DISEASE DIAGNOSIS MARKET: BOTTOM-UP APPROACH
  • FIGURE 4: AUTOIMMUNE DISEASE DIAGNOSIS MARKET: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: ASSUMPTIONS
  • FIGURE 7: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCTS & SERVICES, 2017 VS. 2022 (USD MILLION)
  • FIGURE 8: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 9: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2017 VS. 2022 (USD MILLION)
  • FIGURE 10: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2017 VS. 2022 (USD MILLION)
  • FIGURE 11: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY REGION, 2017 VS. 2022 (USD MILLION)
  • FIGURE 12: HIGH INCIDENCE & LARGE ECONOMIC BURDEN OF AUTOIMMUNE DISEASES-MAJOR FACTOR EXPECTED TO DRIVE MARKET GROWTH
  • FIGURE 13: ROUTINE LABORATORY TESTS SEGMENT TO DOMINATE THE ASIAN AUTOIMMUNE DISEASE DIAGNOSIS MARKET IN 2017
  • FIGURE 14: NORTH AMERICA TO ACCOUNT THE HIGHEST MARKET SHARE IN 2017
  • FIGURE 15: CLINICAL LABORATORIES TO DOMINATE THE AUTOIMMUNE DISEASE DIAGNOSIS MARKET IN 2017
  • FIGURE 16: AUTOIMMUNE DISEASE DIAGNOSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & TRENDS
  • FIGURE 17: CONSUMABLES AND ASSAY KITS TO FORM THE LARGEST PRODUCT SEGMENT IN 2017
  • FIGURE 18: ROUTINE LABORATORY TESTS TO FORM THE LARGEST TEST TYPE SEGMENT IN 2017
  • FIGURE 19: RHEUMATOID ARTHRITIS TO FORM THE LARGEST DISEASE SEGMENT IN 2017
  • FIGURE 20: CLINICAL LABORATORIES TO FORM THE LARGEST END-USER SEGMENT IN 2017
  • FIGURE 21: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY REGION, 2017 VS. 2022 (USD MILLION)
  • FIGURE 22: NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET SNAPSHOT
  • FIGURE 23: CONSUMABLES & ASSAY KITS TO DOMINATE THE NORTH AMERICAN AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT & SERVICE, IN 2017
  • FIGURE 24: ROUTINE LABORATORY TESTS TO DOMINATE THE EUROPEAN AUTOIMMUNE DISEASE DIAGNOSIS MARKET IN 2017
  • FIGURE 25: ASIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET SNAPSHOT
  • FIGURE 26: RHEUMATOID ARTHRITIS TO DOMINATE THE ASIAN AUTOIMMUNE DISEASE DIAGNOSIS MARKET IN 2017
  • FIGURE 27: CLINICAL LABORATORIES SEGMENT TO REGISTER THE HIGHEST GROWTH RATE IN THE ROW AUTOIMMUNE DISEASE DIAGNOSIS MARKET BETWEEN 2017 & 2022
  • FIGURE 28: PRODUCT LAUNCHES, THE MOST ADOPTED GROWTH STRATEGY FROM 2014 TO 2017
  • FIGURE 29: SHARES OF TOP COMPANIES IN THE GLOBAL AUTOIMMUNE DISEASE DIAGNOSIS MARKET 2016
  • FIGURE 30: SIEMENS: COMPANY SNAPSHOT
  • FIGURE 31: ABBOTT: COMPANY SNAPSHOT
  • FIGURE 32: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
  • FIGURE 33: DANAHER: COMPANY SNAPSHOT
  • FIGURE 34: BIO-RAD LABORATORIES: COMPANY SNAPSHOT
  • FIGURE 35: GRIFOLS: COMPANY SNAPSHOT
  • FIGURE 36: TRINITY BIOTECH: COMPANY SNAPSHOT
Back to Top